ACAD
37.08
+1.17
+3.26%
AEMD
7.4
-0.2
-2.63%
APRI
1.66
-0.12
-6.74%
ARNA
2.65
+0.09
+3.52%
ATEC
0.587
+0.007
+1.1724%
CNAT
3.9
+0.17
+4.56%
CRXM
0.35
0.00
0.00%
CYTX
0.353
-0.027
-7.0526%
DXCM
88.28
+0.46
+0.52%
GNMK
9.62
-0.04
-0.41%
HALO
17.46
+0.84
+5.05%
ILMN
195.49
+2.36
+1.22%
INNV
0.11
-0.02
-15.3965%
INO
7.07
-0.03
-0.42%
ISCO
3.82
+0.02
+0.53%
ISIS
51.15
+2.4
+4.92%
LGND
89.13
+0.65
+0.73%
LPTN
0.242
-0.008
-3.0800%
MBVX
1.66
-0.14
-7.78%
MEIP
1.85
+0.05
+2.78%
MNOV
3.077
+0.027
+0.885%
MRTX
27
+0.43
+1.62%
MSTX
0.475
-0.005
-0.9792%
NBIX
49.38
+2.33
+4.95%
NUVA
51.88
-0.13
-0.25%
ONCS
5.71
-0.06
-1.04%
ONVO
2.58
+0.13
+5.31%
OREX
2.72
+0.04
+1.49%
OTIC
21.89
+0.44
+2.05%
QDEL
20.96
+0.68
+3.35%
RCPT
231.96
0.00
0.00%
RGLS
9.03
+0.77
+9.32%
RMD
51.35
+0.6
+1.18%
SCIE
0.014
0.00
0.00%
SPHS
0.865
+0.015
+1.765%
SRNE
12.65
+0.19
+1.52%
TROV
6.13
+0.41
+7.1661%
VICL
0.61
0.00
0.00%
VOLC
18
0.00
0.00%
ZGNX
19.98
+1.5
+8.12%
ACAD
37.08
+1.17
+3.26%
AEMD
7.4
-0.2
-2.63%
APRI
1.66
-0.12
-6.74%
ARNA
2.65
+0.09
+3.52%
ATEC
0.587
+0.007
+1.1724%
CNAT
3.9
+0.17
+4.56%
CRXM
0.35
0.00
0.00%
CYTX
0.353
-0.027
-7.0526%
DXCM
88.28
+0.46
+0.52%
GNMK
9.62
-0.04
-0.41%
HALO
17.46
+0.84
+5.05%
ILMN
195.49
+2.36
+1.22%
INNV
0.11
-0.02
-15.3965%
INO
7.07
-0.03
-0.42%
ISCO
3.82
+0.02
+0.53%
ISIS
51.15
+2.4
+4.92%
LGND
89.13
+0.65
+0.73%
LPTN
0.242
-0.008
-3.0800%
MBVX
1.66
-0.14
-7.78%
MEIP
1.85
+0.05
+2.78%
MNOV
3.077
+0.027
+0.885%
MRTX
27
+0.43
+1.62%
MSTX
0.475
-0.005
-0.9792%
NBIX
49.38
+2.33
+4.95%
NUVA
51.88
-0.13
-0.25%
ONCS
5.71
-0.06
-1.04%
ONVO
2.58
+0.13
+5.31%
OREX
2.72
+0.04
+1.49%
OTIC
21.89
+0.44
+2.05%
QDEL
20.96
+0.68
+3.35%
RCPT
231.96
0.00
0.00%
RGLS
9.03
+0.77
+9.32%
RMD
51.35
+0.6
+1.18%
SCIE
0.014
0.00
0.00%
SPHS
0.865
+0.015
+1.765%
SRNE
12.65
+0.19
+1.52%
TROV
6.13
+0.41
+7.1661%
VICL
0.61
0.00
0.00%
VOLC
18
0.00
0.00%
ZGNX
19.98
+1.5
+8.12%
Home » Archive by Category

Drug Discovery

San Diego’s Antibody-Drug Conjugate Research Highlighted at #WorldADC Meeting in October

November 24, 2014 – 8:11 am
WorldADC

San Diego was host to the World Antibody Drug Conjugate (ADC) Meeting and Awards October 26-29th 2014. ADCs are an exciting new class of oncology therapeutics utilizing monoclonal antibodies conjugated to cytotoxic drugs, resulting in …

SDBN August 21st 2012 Event At The Sanford Consortium For Regenerative Medicine

August 3, 2012 – 12:41 pm

The Sanford Consortium for Regenerative Medicine is a stem cell research facility representing a collaboration between five of San Diego’s finest research institutions: Sanford-Burnham Medical Research Institute, The Salk Institute, The Scripps Research Institute and …

SDBN June 25th Event With Lilly: Open Innovation Drug Discovery

June 4, 2012 – 1:48 am

San Diego biotech has grown thanks to a collaborative spirit which is sometimes manifested in the acquisition and joining of companies towards a common goal. Lilly’s presence here is indicative of this type of growth, …

San Diego’s Biotechnology Companies: Who’s Taking Off?

March 8, 2012 – 9:13 am

Here at SDBN we’ve been updating our directory of 400+ San Diego biotech companies.  We were surprised to find close to 40 companies removed from the local scene – due to acquisition or shut down.  …

SDBN March 26th 2012 Event with Organovo

March 6, 2012 – 1:59 pm

Organovo is an exciting San Diego biotech company with technology to create human tissue through a technique called 3D bioprinting. The tissue can be used for drug discovery and development, and the company has been …

Focus on San Diego: Life Science Conferences Spring 2012

January 31, 2012 – 11:56 am

This spring San Diego downtown will be buzzing with scientific discussions as our city hosts a number of major scientific symposia.  We are excited to attend and soak in all the science that will be …

Virtual Biotech Part 1: What We Learned About Effectively Outsourcing a Drug Discovery Program

July 28, 2011 – 12:04 pm

The first in our Virtual Biotech series, our July 19th event was a success.  Thanks to our participants – some of San Diego’s leading virtual drug discovery scientists and CROs – for sharing their valuable …

SDBN July 19th Event: Virtual Biotech Part 1: How to Effectively Outsource a Drug Discovery Program

July 1, 2011 – 3:47 pm

Changes in the drug discovery landscape have presented many tough challenges for our region, including downsizing for larger companies and a dearth of VC funding for startups. With these challenges come opportunities, however, because drug …

SDBN June 21st Event Featuring aTyr Pharma

May 27, 2011 – 9:58 am

The San Diego Biotechnology Network’s June 21st event will feature aTyr Pharma, with Board Member and CEO Jeffry Watkins (Bio) giving a talk titled “Innovation: Where is our Biology?” aTyr is developing therapeutics based on …

SDBN April 19th 2011 Event Featuring Celgene

March 22, 2011 – 6:15 pm

Through research, acquisitions, and mergers, Celgene has built a robust product portfolio and pipeline in hematology and oncology. This accomplishment is quite a feat in today’s environment, with pharma pipelines dwindling, and they are one …